Director, Mount Auburn Travel Medicine Center; Associate Professor of Medicine Harvard Medical School; Lecturer, MIT; Immediate Past President; International Society of Travel Medicine; Division of Infectious Diseases and Travel Medicine; Mount Auburn Hospital Cambridge, Massachusetts, USA

James D. Cherry, M.D., M.Sc. Distinguished Research Professor of Pediatrics David Geffen School of Medicine at UCLA Member of Division of Infectious Diseases Mattel Children’s Hospital at UCLA Dr. Cherry received his M.D. degree from the University of Vermont in 1957 and his M.Sc. degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983.He was an intern and resident at Boston City Hospital and Kings County Hospital between 1957 and 1960.He served an Infectious Diseases fellowship at the Thorndike Memorial Laboratory and the Harvard Medical Service at Boston City Hospital during 1961 and 1962.He has held faculty positions at the University of Vermont, University of Wisconsin, St. Louis University, and UCLA extending from 1960 to 2021. Dr. Cherry has been involved in research related to vaccine preventable diseases since 1966. Professor James D. Cherry has been a pediatric infectious diseases specialist for 58 years. Presently, Professor Cherry is a Distinguished Research professor of Pediatrics at the David Geffen School of Medicine at the University of California, Los Angeles, USA. Following his infectious diseases fellowship training, Professor Cherry established one of the first formal pediatric infectious diseases fellowship programs in the world in 1963 at the University of Wisconsin, USA. Following this he ran a similar program at Saint Louis University and then since 1973, he has been at UCLA. During his 46 year tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the United States and in other countries throughout the world. In 1969-70, Professor Cherry was a visiting worker at the Medial Research Council, Common Cold Research Unit and Clinical Research Centre, Salisbury, England. In 1971-1972 ad 1977-1979, Professor Cherry studied measles and measles vaccines and more recently, complications relating to measles. From 1989 to 1996, Professor Cherry with Professor Stehr and Professor Ulrich Heininger carried out an extensive pertussis vaccine efficacy trial in Erlangen, Germany. In 2000-2001, he was a visiting scholar in the Department of Clinical Veterinary Medicine, University of Cambridge, England. Professor Cherry has published 325 research papers, 108 editorials and commentaries and 303 book chapters. He is the senior editor of Feigin and Cherry’s Textbook of Pediatric Infectious Diseases which is now in its 8th edition.

Julie Copelyn is a paediatric infectious diseases sub-specialist. She received her MBBS from the University of Sydney in 2007, before returning home to South Africa. She holds an MSc in Paediatrics and Child Health (Global Health) from University College London and is a member of the founding committee of Young WSPID. Her interests include paediatric HIV and TB, vaccine preventable illnesses and antimicrobial stewardship.

Mark is outgoing president of WSPID. He has been a board member since 2013. He is an internationally acclaimed specialist in paediatric infectious diseases with extensive experience in managing children living with HIV. He has led the Children's Infectious Diseases Clinical Research Unit (KidCru) (renamed the Family Center for Research with Ubuntu [FAMCRU]) in randomised clinical trials in children, including antiretroviral therapy (ART) strategy, isoniazid prophylaxis and antiretroviral (ARV) pharmacokinetics in children. He completed a three year fellowship in paediatric infectious diseases at the University of Colorado-Denver, and also conducted laboratory-based research on apoptosis in paediatric HIV supervised by Dr Terri Finkel at the National Jewish Centre for Respiratory Diseases and Immunology. On return to Stellenbosch University, he completed a PhD on the role of apoptosis in paediatric HIV infection. He has since been conducting multicentre trials focusing on Tuberculosis (TB) and HIV in children. He is affiliated to the International Maternal Paediatric Adolescent AIDS Clinical Trials (IMPAACT) and Paediatric European Network for Treatment of AIDS (PENTA) networks and has provided technical support for the World Health Organisation initiatives since 2004 on the Classification for HIV, antiretroviral guidelines and TB-HIV co-infection. He is co-principal investigator for the Stellenbosch University Clinical Trials Unit (SUN-CTU) with special focus on TB and HIV.

Pediatric Infectious Diseases Specialist in Mexico City with special Interest in Childhood Tuberculosis and Prevention and Infection Control

I am the Head of the Section of Paediatric Infectious Disease at Imperial College, and an Honorary Consultant in Paediatric Infectious Diseases at St Mary's Hospital, Imperial College Healthcare NHS Trust. My research focuses on the interactions between hosts and pathogens which result in severe infectious diseases, particularly severe malaria. I am interested in understanding why some people get very ill and die from malaria, whilst others have a less severe illness. I am co-convener of the Imperial College Network of Excellence in Malaria, an interdisciplinary network of more than 100 malaria researchers at Imperial College working together to eradicate malaria. I also lead the international Digital Diagnostics for Africa Network, developing innovative diagnostic tools to facilitate malaria eradication efforts.